Sandoz’s Tyruko (natalizumab), the only FDA approved natalizumab biosimilar for adults with relapsing multiple sclerosis and Crohn’s disease, is now available by prescription in the United States ...

Tyruko ® (natalizumab-sztn), a biosimilar to Tysabri ® (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics.

Macrophages can alternate between two states: an inflammatory state for fighting infection and a non-inflammatory state for ...

By JESSICA N. REX [email protected] This article is part of the “Meet Your Neighbor Monday” series, highlighting the stories of individuals who make Warren County a special place to live. If you ...

Mutations in a gene associated with Crohn's disease have been found to rob critical immune cells of their ability to switch ...

Thanks to COVID-era discussions, the 2023 coverage of a Delta passenger who had diarrhea in their seat (I cannot imagine), ...

Nutritional status plays a critical role throughout the disease course of inflammatory bowel diseases (IBD). Patients ...

Silent Crohn’s disease' is a form of inflammatory bowel disease that may develop without typical or obvious symptoms.

CU Anschutz researchers uncovered a link between a type of mucosal immune cell and gut inflammation, finding that the cells ...

NeuroScientific Biopharmaceuticals dosed a fourth Crohn’s patient with its StemSmart therapy ahead of phase 2 trials for its ...